(Q45019905)

8 December 2017

0 references

A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents (English)

1 reference

8 December 2017

0 references

4

1 reference

8 December 2017

Mohan N Babapulle

1

1 reference

8 December 2017

Lawrence Joseph

series ordinal

2

1 reference

8 December 2017

Patrick Bélisle

series ordinal

3

1 reference

8 December 2017

Mark J Eisenberg

series ordinal

5

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

364

1 reference

8 December 2017

583-591

1 reference

8 December 2017

9434

1 reference

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Evidence for use of coronary stents. A hierarchical bayesian meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Pathology of Acute and Chronic Coronary Stenting in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Coated stents for the prevention of restenosis: Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

New frontiers in cardiology: drug-eluting stents: Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Stent thrombosis after successful sirolimus-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Regional remodeling as the cause of late stent malapposition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Late incomplete apposition with excessive remodeling of the stented coronary artery following intravascular brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

A paclitaxel-eluting stent for the prevention of coronary restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Coronary in-stent restenosis - predictors, treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Clinical and angiographical follow-up after implantation of a 6--12 microCi radioactive stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Drug eluting stents: are human and animal studies comparable?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

Radioactive stents delay but do not prevent in-stent neointimal hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916850-5

7 January 2021

10.1016/S0140-6736(04)16850-5

Identifiers

DOI

1 reference

8 December 2017

1 reference